From the Journals

Recently approved SK treatment spares melanocytes in preclinical study


 

FROM JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY


Tunel staining revealed 16.4 (plus or minus 0.6424) apoptotic cells per high-powered field in the 5-second cryosurgery experiment and 20.6 (plus or minus 0.6424) in the 10-second procedure. For the hydrogen peroxide treatment, those numbers were 8.65 (plus or minus 0.4122) in the 1 mcL experiment and 12.4 (plus or minus 0.3728) in the 2 mcL experiment.

As expected, melanocytes fared better with the hydrogen peroxide treatment. In the untreated samples, there were 2.5 melanocytes (plus or minus 0.1987) in the untreated sample and 2.0 (plus or minus 0.5000) melanocytes in the vehicle-treated sample. In the 5-second cryosurgery sample, there were 0.45 melanocytes (plus or minus 0.1535), and in the 10 second cryosurgery sample there were 0.2 (plus or minus 0.0918) melanocytes. In contrast, with the 1-mcL hydrogen peroxide-treated sample, there were 1.95 melanocytes in both the 1-mcL and 2-mcL samples (plus or minus 0.1535 for both groups).

From a cytotoxicity perspective, [40% hydrogen peroxide] was much less toxic to the epidermis than the liquid nitrogen,” Dr. Friedman said. These results, he added, “offer us a lot of insight in terms of how damaging liquid nitrogen is, and it’s good to be reminded of that so that we don’t cause too much harm.”

The authors noted that a clinical trial evaluating the risk of hypopigmentation and hyperpigmentation with 40% hydrogen peroxide in people with darker skin types is underway. In the study, hydrogen peroxide is used to treat dermatosis papulosa nigra.

The study was funded by Aclaris Therapeutics. Senior author Adam Friedman, MD, is a consultant for Aclaris. Dr. Friedman is on the editorial board of Dermatology News.

SOURCE: Kao S et al. J Am Acad Dermatol. 2018 Mar 27. doi: 10.1016/j.jaad.2018.03.034.

Pages

Recommended Reading

Make the Diagnosis - March 2018
MDedge Dermatology
FDA alerts doctors to stop administering compounded products
MDedge Dermatology
2018 Hidradenitis Suppurativa 4-Part Video Roundtable
MDedge Dermatology
Make The Diagnosis - April 2018
MDedge Dermatology
Bacteria seen as potential lupus triggers
MDedge Dermatology
Pilot study: Topical anticholinergic improved axillary hyperhidrosis in teens, young adults
MDedge Dermatology
Lenalidomide yields responses in a rare cutaneous lymphoma
MDedge Dermatology
From weekend warriors to pros, athletes are plagued by skin disorders
MDedge Dermatology
Prioritize topical treatments in pregnant women
MDedge Dermatology
Why do people act that way?
MDedge Dermatology